Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Takeda Pharmaceutical Co. Ltd.

http://www.takeda.com

Latest From Takeda Pharmaceutical Co. Ltd.

Dengue Swells As US Vaccine Prospects Recede

Sanofi’s voluntary Dengvaxia withdrawal due to low demand leaves the US with no dengue vaccine, even as Puerto Rico declares a public health emergency and global cases rise.

Vaccines Infectious Diseases

Wave Chasing Huntington’s Accelerated Approval Based On Caudate Atrophy Surrogate

The biotech plans a pivotal trial that would support accelerated approval of the Takeda-partnered antisense oligonucleotide, WVE-003, and will discuss it with regulators before the end of the year.

Clinical Trials Neurology

Finance Watch: Alumis Launches IPO In Market Less Receptive Than Expected

Public Company Edition: Alumis grosses $250m after it planned to raise up to $317.7m in its IPO. Also, Zealand adds $1bn in a post-data offering, Tectonic and Eliem close $130.7m and $120m private placements to support recent mergers, and Ginkgo cuts 35% of its workforce.

Financing Business Strategies

Ensho Joins Race To Develop An Oral Integrin Inhibitor For IBD

Ensho Therapeutics is raising series A cash to develop Phase II-ready NSHO-101 (EA1080), a third oral ɑ4β7 integrin inhibitor attempting to take on Takeda’s blockbuster injectable Entyvio.

Deals StartUps and SMEs
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Other Names / Subsidiaries
    • Adaptate Biotherapeutics Ltd
    • Altos Therapeutics LLC
    • AR Scientific, Inc. (URL)
    • ARIAD Pharmaceuticals, Inc.
    • Bradley Pharmaceuticals, Inc
    • Cellerix SA
    • Cerevance, Envoy Therapeutics, Inc.
    • Chordia Therapeutics
    • ChromaJean, Inc.
    • GammaDelta Therapeutics
    • IDM Pharma
    • Intellikine, Inc.
    • Inviragen, Inc.
    • LigoCyte Pharmaceuticals, Inc.
    • Maverick Therapeutics, Inc.
    • Millennium Pharmaceuticals, Inc.
    • Mutual Pharmaceutical Company, Inc. (URL)
    • Neutec
    • Nihon Pharmaceutical Co., Ltd
    • Nycomed Pharma AS
    • Pharmaceutical Holdings Corporation (URL)
    • PvP Biologics, Inc.
    • sanaplasma AG
    • Syrrx, Inc.
    • TAP Pharmaceutical Products, Inc.
    • Teva Takeda Pharma Ltd.
    • Shire Pharmaceuticals Group PLC (SHPG)
    • Teva Takeda Yakuhin Ltd.
    • TiGenix NV
    • URL Pharma, Inc. Advanced BioHealing, Inc. (renamed Shire Regenerative Medicine)
    • AesRX LLC
    • Baxalta Incorporated
    • BIKAM Pharmaceuticals Inc.
    • Chatham Therapeutics
    • Dyax Corp.
    • FerroKin BioSciences, Inc.
    • Fibrotech Therapeutics
    • Foresight Biotherapeutics Inc.
    • Gambro AB
    • Immuno-US
    • Jerini AG
    • Lotus Tissue Repair
    • Lumena Pharmaceuticals
    • Meritage Pharma, Inc.
    • Movetis NV
    • New Pervasis Therapeutics, Inc.
    • NPS Pharmaceuticals, Inc.
    • Premacure AB
    • Prism Pharmaceuticals, Inc.
    • River Pharmaceuticals
    • Roberts Pharmaceutical Corporation
    • SARcode Corporation
    • SuppreMol GmbH
    • Synovis Life Technologies, Inc.
    • Transkaryotic Therapies, Inc.
    • ViroPharma Inc.
UsernamePublicRestriction

Register